Translating gene expression into clinical care: sarcomas as a paradigm.
about
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testingGene expression profiling of solitary fibrous tumors.Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.Patient-derived xenografts for individualized care in advanced sarcoma.Histologic and genetic advances in refining the diagnosis of "undifferentiated pleomorphic sarcoma"Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionMultimodality therapy for metastatic sarcomas confined to the lung.The in ovo CAM-assay as a xenograft model for sarcomaEffective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.Ameloblastoma: a clinical review and trends in management.Morphometric and cytomorphologic characterization of EGFR-mutated cancer cells-comparison between cultured lung cancer cell lines and lung adenocarcinoma clinical samples.Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinomaCINSARC: a new look into an old concept gives hope for new treatments for synovial sarcomas.Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma.[Sarcoma gene signatures].
P2860
Q28741842-B7BAB535-1408-41D5-88D3-E8B6D9B968BAQ33408187-26D01964-975D-4CBC-A2A8-E487A1B8B134Q33910538-8955C0DE-3699-4AAC-A3B0-11750107F623Q34413869-2898ADE5-BCE8-43D4-A4D6-A4543C606ECBQ34657369-E57F5909-E34B-45BF-97D1-EF73AD133AA4Q35767389-CCDDA0B0-4EF6-4373-9D47-5E5FBFBF234EQ36424138-7DF28267-021A-4F5A-9F21-B506CF33088AQ37354267-BA993C06-4B5D-4BDF-88DE-E169BB3F30BAQ37565198-A9C983EA-1656-442F-B4D7-AC533FEF0BB9Q38083828-BF9D5CDC-8705-411E-ABBF-F102BCEBC8C2Q38150909-5F7151B7-1AD0-416F-AA22-A9CE548B62C2Q38397179-82BC3739-69B1-4DFE-B62A-6478C01925F3Q38450434-E1440CD0-277C-4384-8CB8-6135B0625489Q38765690-D6858E1B-4ACD-4D65-9908-61DB35BDC500Q39564761-AAB521F3-E9DD-408D-8C03-78CB80B2FA5FQ40033130-5B2DE08F-7313-4597-AFBA-69502ECA9065Q40883588-D72671D7-FAFD-4F33-8959-52DA5963B135Q47793357-DEFCA3A9-3DFB-4654-8C2C-9729D0C42C9FQ51098298-E380D21F-AAA3-42D3-9B03-233C3288FB0DQ52655025-760D51E4-4A7B-4F4D-AC19-6BC7E53BC7C6Q54389752-A604F793-C49C-4D5B-8EF9-7722079FE38C
P2860
Translating gene expression into clinical care: sarcomas as a paradigm.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Translating gene expression into clinical care: sarcomas as a paradigm.
@en
Translating gene expression into clinical care: sarcomas as a paradigm.
@nl
type
label
Translating gene expression into clinical care: sarcomas as a paradigm.
@en
Translating gene expression into clinical care: sarcomas as a paradigm.
@nl
prefLabel
Translating gene expression into clinical care: sarcomas as a paradigm.
@en
Translating gene expression into clinical care: sarcomas as a paradigm.
@nl
P356
P1476
Translating gene expression into clinical care: sarcomas as a paradigm.
@en
P2093
Robert B West
Torsten O Nielsen
P304
P356
10.1200/JCO.2009.26.1917
P407
P577
2010-03-01T00:00:00Z